Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

Contact Us

Search

Inflammation

Public_Health

Public Health Today—23 January, 2026

This week's Public Health update highlights advances in diagnostics,…

Immunology

Immunology Today—November 5, 2025

Catch the latest immunology news, featuring industry updates, clinical…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Angitia Biopharmaceuticals $130 million Series D
Vaccines Video Recap—February 6, 2026
Respiratory Video Recap—February 6, 2026
Public Health Today—February 6, 2026
Vaccines Today—February 6, 2026

Tags

AHA 2025 AI for Science AI in Aesthetics Amycretin AtriCure Biorep Technologies Bispecific antibody therapy blood biomarkers BMJ cancer CB1 pathway Clinical Decision-Making Dayra Therapeutics Debio 4126 EADV 2025 Elismetrep Elranatamab ENHANZE EpiEndo Pharmaceuticals FDA oncology approvals Fenfluramine G6PD deficiency Heartnote heart valve treatment hematology Hematology strategy Ischemic heart disease Lilly ExploR&D mitapivat mRNA therapeutics muscarinic Nipah virus infection non viral vectors Obesity strategy pediatric urology peptibody mRNA therapy pharma Psychiatric disorders Recessive dystrophic epidermolysis bullosa Rybrevant FASPRO Samsung Bioepis Sema4 T-cell engagers Thermo Fisher TNFα

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Angitia Biopharmaceuticals $130 million Series D
Vaccines Video Recap—February 6, 2026
Respiratory Video Recap—February 6, 2026
Public Health Today—February 6, 2026
Vaccines Today—February 6, 2026

TAGS

AHA 2025 AI for Science AI in Aesthetics Amycretin AtriCure Biorep Technologies Bispecific antibody therapy blood biomarkers BMJ cancer CB1 pathway Clinical Decision-Making Dayra Therapeutics Debio 4126 EADV 2025 Elismetrep Elranatamab ENHANZE EpiEndo Pharmaceuticals FDA oncology approvals Fenfluramine G6PD deficiency Heartnote heart valve treatment hematology Hematology strategy Ischemic heart disease Lilly ExploR&D mitapivat mRNA therapeutics muscarinic Nipah virus infection non viral vectors Obesity strategy pediatric urology peptibody mRNA therapy pharma Psychiatric disorders Recessive dystrophic epidermolysis bullosa Rybrevant FASPRO Samsung Bioepis Sema4 T-cell engagers Thermo Fisher TNFα

Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy